Geri Dön

Probabilistic latent factor modelsfor transformative drug discovery

Başlık çevirisi mevcut değil.

PDF İndir

  1. Tez No: 759871
  2. Yazar: MURAT CAN COBANOGLU
  3. Danışmanlar: DR. ZİV BAR-JOSEPH
  4. Tez Türü: Doktora
  5. Konular: Biyomühendislik, Biyoloji, Biyoteknoloji, Bioengineering, Biology, Biotechnology
  6. Anahtar Kelimeler: Belirtilmemiş.
  7. Yıl: 2015
  8. Dil: İngilizce
  9. Üniversite: Unıversıty Of Pıttsburgh
  10. Enstitü: Yurtdışı Enstitü
  11. Ana Bilim Dalı: Belirtilmemiş.
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: Belirtilmemiş.

Özet

Özet yok.

Özet (Çeviri)

: The cost of discovering a new drug has doubled every 9 years since the 1950s. This can change by using machine learning to guide experimentation. The idea I have developed over the course of my PhD is that using latent factor modeling (LFM) of the drug-target interaction network, we can guide drug repurposable efforts to achieve transformative improvements. By better characterizing the drug-target interaction network, it is possible to use currently approved drugs to achieve therapies for diseases that currently are not optimally treated. These drugs might be directly used through repurposing, or they can serve as a starting point for new drug discovery efforts where they are optimized through medicinal chemistry methods. To achieve this goal, I have developed LFM-based techniques applicable to existing databases of drug-target interaction networks. Specifically, I have started out by establishing that probabilistic matrix factorization (PMF; one type of LFM algorithm) can be used as descriptors by showing they capture therapeutic function similarities that state-of-the-art 3D chemical similarity methods could not capture. Then I have shown that PMF can effectively predict unknown drug-target interactions. Furthermore, I have used newly developed computational techniques for discovering repurposable drugs for two diseases, α1 antitrypsin (1-AT) deficiency (ATD) and Huntington's disease (HD) leading to successful discoveries in both. For ATD, two sets of data generated by the David Perlmutter and Gary Silverman laboratories have been used as input to deduce potential targets and repurposable drugs: (i) a high throughput screening data from a genomewide RNAi knockdown in a C. elegans model for studying ATZ (Z-allele of 1-AT), and (ii) data from Prestwick library screen for the same model. We have predicted that the antidiabetic drug glibenclamide would be beneficial against ATZ aggregation, and data collected to date in Mus musculus models are promising. We have worked on HD with the Robert Friedlander lab, v by examining the potential drugs and implicated pathways for 15 neuroprotective (repurposable) drugs that they have identified in a two-stage screening study. Based on LFM-based analysis of the targets of these drugs, we have developed a number of hypotheses to be tested. Among them, the antihypertensive drug sodium nitroprusside appears to be effective against HD based on neuronal cell death inhibition experiments that were conducted at the University of Pittsburgh Drug Discovery Institute as well as the Friedlander lab. Finally, we have built a web server, named BalestraWeb, for facilitating the use of PMF in repurposable drug identification by the broader community. BalestraWeb enables users to extract information on known and potential targets (or drugs) for any approved drug (or target), simply by entering the name of the query drug (or target). I have also laid out the framework for developing an integrated resource for quantitative systems pharmacology, Balestra toolkit (BalestraTK), which would take advantage of existing databases such as STITCH, UniProt, and PubChem. Collectively, our results provide firm evidence for the potential utility of machine learning techniques for assisting in drug discovery.

Benzer Tezler

  1. Tez No

    959126

    Data-driven anomaly detection for airspace security using ADS-B surveillance data

    ADS-B gözetim verisi ile hava sahası güvenliği için veri tabanlı anomali tespiti

    ABDULLAH ÇERKEZOĞLU

    Yüksek Lisans

    İngilizce

    İngilizce

    2025

    Savunma ve Savunma Teknolojileriİstanbul Teknik Üniversitesi

    Savunma Teknolojileri Ana Bilim Dalı

    DOÇ. BARIŞ BAŞPINAR

  2. Tez No

    402987

    Learning mental states from biosignal

    Başlık çevirisi yok

    MELİH KANDEMİR

    Doktora

    İngilizce

    İngilizce

    2013

    Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve KontrolAalto Unıversıty (aalto Ylıopısto)

    PROF. SAMUEL KASKI

    DR. ARTO KLAMI

  3. Tez No

    325527

    Probabilistic tensor factorization for link prediction

    Bağlantı tamini için olasılıksal tensör ayrışımı

    BEYZA ERMİŞ

    Yüksek Lisans

    İngilizce

    İngilizce

    2012

    Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve KontrolBoğaziçi Üniversitesi

    Bilgisayar Mühendisliği Ana Bilim Dalı

    DOÇ. ALİ TAYLAN CEMGİL

  4. Tez No

    338831

    Probabilistic time series classification

    Olasılıksal zaman serisi sınıflandırma

    YUSUF CEM SÜBAKAN

    Yüksek Lisans

    İngilizce

    İngilizce

    2013

    Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve KontrolBoğaziçi Üniversitesi

    Elektrik-Elektronik Mühendisliği Ana Bilim Dalı

    PROF. DR. BÜLENT SANKUR

    DOÇ. DR. ALİ TAYLAN CEMGİL

  5. Tez No

    978070

    Nöromorfik hesaplama ve memristor tabanlı ağ saldırı tespit sistemleri: Siber güvenlikte yeni yaklaşımlar

    Neuromorphic computing and memristor-based network attack detection systems: New approaches in cyber security

    YUSUF ETKA KÖYLÜ

    Yüksek Lisans

    Türkçe

    Türkçe

    2025

    Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve Kontrolİstanbul Teknik Üniversitesi

    Mekatronik Mühendisliği Ana Bilim Dalı

    PROF. DR. İLHAN KOCAARSLAN

Geri Dön